Cargando…
Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
Bladder cancer (BLCA) is one of the most common urological cancer with increasing cases and deaths every year. In the present study, we aim to construct an immune‐related prognostic lncRNA signature (IRPLS) in bladder cancer (BLCA) patients and explore its immunogenomic implications in pan‐cancers....
Autores principales: | Luo, Wen‐Jie, Tian, Xi, Xu, Wen‐Hao, Qu, Yuan‐Yuan, Zhu, Wen‐Kai, Wu, Jie, Ma, Chun‐Guang, Zhang, Hai‐Liang, Ye, Ding‐Wei, Zhu, Yi‐Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093983/ https://www.ncbi.nlm.nih.gov/pubmed/33797188 http://dx.doi.org/10.1111/jcmm.16494 |
Ejemplares similares
-
A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
por: Yu, Zuhu, et al.
Publicado: (2022) -
Construction of an lncRNA model for prognostic prediction of bladder cancer
por: Shi, Changlong, et al.
Publicado: (2022) -
Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021) -
Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021) -
Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)